PMID- 34496493 OWN - NLM STAT- MEDLINE DCOM- 20210910 LR - 20210910 IS - 0529-5807 (Print) IS - 0529-5807 (Linking) VI - 50 IP - 9 DP - 2021 Sep 8 TI - [Inflammatory myofibroblastic tumors of the urinary bladder: a clinicopathological study of ten cases]. PG - 1024-1028 LID - 10.3760/cma.j.cn112151-20210113-00039 [doi] AB - 0bjective To investigate the clinicopathological features,immunohistochemical phenotypes, molecular genetic alterations,diagnosis and differential diagnosis of inflammatory myofibroblastic tumor (IMT) of the urinary bladder. Methods: Ten cases of IMT of the urinary bladder (three cases at Ningbo Diagnostic Pathology Center from September 2011 to December 2020, five in-house diagnosed cases and two consultation cases at Shanghai Rui Jin Hospital from June 2011 to December 2020) were collected retrospectively. The clinicopathologic features and immunophenotypic profiles were studied by light microscopy and immunohistochemistry (EnVision method). The translocation of ALK gene was detected by fluorescence in situ hybridization (FISH). Results: Of the 10 patients, eight were male and two were female. The patients' age range was 16 to 62 years (median 36 years).The main clinical presentation was hematuria and urinary irritation. Three cases were located at the dome of the urinary bladder, four cases were in the left lateral wall and the remaining three cases were in the right lateral wall. The tumor size ranged from 1.5 cm to 8.5 cm. In eight cases, the tumors were mainly submucosal, and in some cases extending to the muscular layer of the urinary bladder. In two cases, the tumors were mainly located in the muscular layer and focally extended to the submucosa and adventitia. Histologically, four cases had the nodular fasciitis-like pattern, three cases had fibrohistiocytoma-like pattern, two cases had mixed histologic patterns and the remaining case showed leiomyosarcoma-like histologic features. Immunohistochemically, the tumor cells expressed SMA (10/10),calponin (9/10),desmin (6/10) and CKpan (9/10). Cytoplasmic staining for ALK1 and ALK (5A4) was detected in 7 of 10 cases and 8 of 10 cases, respectively. Nuclear and cytoplasmic staining for ALK (D5F3) was detected in 7 of 10 cases. Among eight cases with material available for FISH analysis, ALK rearrangement was present in five cases. Follow-up data were available in eight patients and none had local recurrence nor distant metastasis. Conclusion: IMT of the urinary bladder is an uncommon mesenchymal neoplasm with intermediate malignant potential.It has special clinicopathologic features, and a minority of cases have local tumor recurrence. FAU - Zhang, H Z AU - Zhang HZ AD - Department of Pathology, Ningbo Diagnostic Pathology Center, Zhejiang Province, Ningbo 315000, China. FAU - Wang, S Y AU - Wang SY AD - Department of Pathology, Ningbo Diagnostic Pathology Center, Zhejiang Province, Ningbo 315000, China. FAU - Dong, L AU - Dong L AD - Department of Pathology, Rui Jin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200020, China. FAU - Yang, X Q AU - Yang XQ AD - Department of Pathology, Rui Jin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200020, China. FAU - Wang, C F AU - Wang CF AD - Department of Pathology, Rui Jin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200020, China. LA - chi PT - Journal Article PL - China TA - Zhonghua Bing Li Xue Za Zhi JT - Zhonghua bing li xue za zhi = Chinese journal of pathology JID - 0005331 RN - 0 (Biomarkers, Tumor) RN - EC 2.7.10.1 (Anaplastic Lymphoma Kinase) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) SB - IM MH - Adolescent MH - Adult MH - Anaplastic Lymphoma Kinase/genetics MH - Biomarkers, Tumor MH - China MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence MH - Male MH - Middle Aged MH - Receptor Protein-Tyrosine Kinases/genetics MH - Retrospective Studies MH - *Urinary Bladder Neoplasms/genetics MH - Young Adult EDAT- 2021/09/10 06:00 MHDA- 2021/09/11 06:00 CRDT- 2021/09/09 03:52 PHST- 2021/09/09 03:52 [entrez] PHST- 2021/09/10 06:00 [pubmed] PHST- 2021/09/11 06:00 [medline] AID - 10.3760/cma.j.cn112151-20210113-00039 [doi] PST - ppublish SO - Zhonghua Bing Li Xue Za Zhi. 2021 Sep 8;50(9):1024-1028. doi: 10.3760/cma.j.cn112151-20210113-00039.